Digestive Health
Available Digestive Health Trials:
- (179-20) A Multicenter, Randomized, Double-Blind, Placebo-Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects with Ulcerative Colitis
- (263-20) A study of CDPATH™ to Help Manage and Treat Crohn’s Disease (COMPASS-CD)
- (126-22) Treat-to-Target of Endoscopic Remission in Patients with IBD in Symptomatic Remission: The QUOTIENT Trial
- (194-22) A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn’s Disease (DUET-CD)
- (193-23) A Phase 2b Multicenter, Randomized, Placebo- Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Moderately to Severely Active Ulcerative Colitis
To learn more about available clinical trials, please at 949-764-4577 or clinicalresearch@hoag.org.